John Libbey Eurotext

Journal de Pharmacie Clinique

MENU

Proper and safe use of inhaled therapeutics: which role play healthcare professionals in supporting chronic asthma and COPD patients care? Knowledge and practices in a French hospital Volume 41, issue 2, Juin 2022

Figures

  • Figure 1.
  • Figure 2.
  • Figure 3.
  • Figure 4.
  • Figure 5.
  • Figure 6.
  • Figure 7.

Tables

Authors
1 Pharmacie, Centre hospitalier Rives de Seine, 36, bd du Général Leclerc, 92205 Neuilly-sur-Seine, France
2 Spécialités médicales, Centre hospitalier Rives de Seine, 36, bd du Général Leclerc, 92205 Neuilly-sur-Seine, France
3 Gériatrie, Centre hospitalier Rives de Seine, 36, bd du Général Leclerc, 92205 Neuilly-sur-Seine, France
Correspondance : R. Guimaraes

The proper use of the various inhaler devices prescribed in asthma/chronic obstructive pulmonary disease (COPD) isn’t systematically respected by the patients, leading to a potential poor disease control. Patient education is essential, and revaluation of the inhalation techniques seems to be necessary for some patients, especially in case of exacerbations/asthma attacks. In those situations, the revaluation of these therapeutics at hospital can be necessary.

A survey was conducted in July/August 2019 in a general hospital in France to evaluate nurses’ and clinicians’ knowledge about asthma/COPD management and to make an assessment of the current practices. Two questionnaires were elaborated for nurses/clinicians.

Thirty-seven nurses and 16 clinicians participated. Regarding the pathophysiology and management of asthma/COPD, the nurses obtained 69 % of correct answers. The mean percentage of compliance of the nebulization practices was 38 %. Only 49 % of nurses systematically carry out an evaluation of patients’ autonomy to use their inhaler device and 68.8 % of clinicians answered being “not at all” or “little” comfortable with inhalation techniques.

We noted an insufficient mastery from nurses concerning asthma/COPD physiopathology and therapeutics and a poor compliance rate of the prescription/administration practices of nebulized medicines. The evaluation of inhaler devices use in patients is not structured. An action plan was implemented including professionals training, the access to resources and tools for healthcare professionals in order to improve the health care pathway.